Skip to main content
. Author manuscript; available in PMC: 2024 Feb 2.
Published in final edited form as: Lancet Diabetes Endocrinol. 2023 Dec 4;12(1):39–50. doi: 10.1016/S2213-8587(23)00321-2

Figure 1. Effect of allocation to empagliflozin on acute changes in estimated glomerular filtration rate, by key subgroups.

Figure 1

P values for test of heterogeneity between absolute differences for patients with and without diabetes and tests for trend in absolute differences across eGFR and UACR categories are 0.0010, 0.016 and 0.050 respectively.